Gefitinib-resveratrol Cocrystal with Optimized Performance in Dissolution and Stability
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference29 articles.
1. Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation;Fukuhara;Lung Cancer,2015
2. Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer;Nishio;Lung Cancer,2015
3. EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells;Sugita;Biochem Biophys Res Commun,2015
4. Synthesis of novel gefitinib-based derivatives and their anticancer activity;Sharma;Arch Pharm,2019
5. FDA approval of gefitinib for the treatment of patients with metastatic EGFR mutation-positive non-small cell lung cancer;Kazandjian;Clin Cancer Res,2016
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cocrystals of carbamazepine: Structure, mechanical properties, fluorescence properties, solubility, and dissolution rate;Particuology;2024-07
2. Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma;Pharmacia;2024-01-25
3. Resveratrol Supplements Reduce the Risk of Aging-Related Cardiac Disease after Cardiorespiratory Fitness;Resveratrol - Recent Advances, Application, and Therapeutic Potential [Working Title];2023-03-13
4. Resveratrol and Its Role in the Management of B-Cell Malignancies—A Recent Update;Biomedicines;2023-01-15
5. Novel pharmaceutical co-crystals of gefitinib: synthesis, dissolution, cytotoxicity, and theoretical studies;CrystEngComm;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3